NCT00798395View on ClinicalTrials.gov

A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Sleep Initiation and Maintenance DisordersMental Disorders
Interventions
DRUG

Org 50081

1.5 mg on day 1-7

DRUG

Org 50081

4.5 mg on Day 1-7

DRUG

Placebo

Once daily on Day 1-7

DRUG

zopiclone

Single dose of 7.5 mg

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00798395 - A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED) | Biotech Hunter | Biotech Hunter